Drug Demand Reduction Act
Executive Summary
Drug abuse legislation (H.R. 4550) passes House Sept. 16 with provision directing HHS to conduct a study regarding the need for financial incentives to encourage the development of anti-addiction drugs. Bill managers Portman (R-Ohio) and Hastert (R-Ill.) proposed the amendment in response to initial bill language that would have given manufacturers of anti-addiction products the right to extend the exclusivity of a different marketed product upon the approval of the anti-addiction agent